Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review

@article{Dimmock2000EfficacyOS,
  title={Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review},
  author={Paul Dimmock and Katrina M Wyatt and Peter W. Jones and P M Shaughn O'Brien},
  journal={The Lancet},
  year={2000},
  volume={356},
  pages={1131-1136}
}
Review: selective serotonin reuptake inhibitors reduce symptoms in premenstrual syndrome
TLDR
No difference in the effectiveness of SSRIs existed when comparing continuous and intermittent doses or between trials funded by pharmaceutical companies and those funded otherwise.
Selective serotonin reuptake inhibitors for premenstrual syndrome.
TLDR
The evidence supports the use of selective serotonin reuptake inhibitors in the management of severe premenstrual syndrome.
Selective serotonin reuptake inhibitors for premenstrual syndrome.
TLDR
SSRIs were found to be highly effective in treating premenstrual symptoms and there was no significant difference between trials funded by pharmaceutical companies and those independently funded.
Selective Serotonin Reuptake Inhibitors and Initial Oral Contraceptives for the Treatment of PMDD: Effective But Not Enough
TLDR
In the majority of larger-scale studies, once the placebo effect is accounted for, the percentage of women who respond to SSRIs or COCs is actually less than the percentageof women who do not respond at all.
Selective Serotonin Reuptake Inhibitors for Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Meta-Analysis
TLDR
A meta- analysis demonstrates that SSRIs are effective for treating PMS and premenstrual dysphoric disorder, with continuous dosing regimens favored for effectiveness.
Selective Serotonin Reuptake Inhibitors for Premenstrual Dysphoric Disorder
TLDR
Treatments that enhance serotonergic action improve premenstrual irritability and dysphoria with a rapid onset of action, suggesting a different mechanism of action than in the treatment of depression.
Citalopram in PMS patients with prior SSRI treatment failure: a preliminary study.
TLDR
Results from a small number of subjects with open-label treatment suggest that citalopram treatment is effective for PMS patients who failed previous SSRI treatment, and all DSR factor scores significantly improved.
The Effects Of Selective Serotonin Reuptake Inhibitor (Sertraline) On Premenstrual Tension Syndrome
TLDR
It is found that sertraline has no substantial effects on EEG findings, simply it relieved the clinical symptoms, and recommend use of SSRIs in the treatment of PMS.
Paroxetine Controlled Release for Premenstrual Dysphoric Disorder: A Double-Blind, Placebo-Controlled Trial
TLDR
Both doses of paroxetine CR 12.5 mg and 25 mg daily are effective and well tolerated in patients who suffer from PMDD, and effectiveness with both doses affords greater flexibility to the prescribing physician.
...
...

References

SHOWING 1-10 OF 40 REFERENCES
Treatment of Premenstrual Syndrome With Fluoxetine: A Double‐Blind, Placebo‐Controlled, Crossover Study
TLDR
Fluoxetine appears to be a highly effective, well-tolerated treatment for the psychological and physical symptoms accompanying severe PMS.
Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial.
TLDR
Sertraline and possibly desipramine appear to be effective treatments for PMS, and sertralines was better tolerated, resulting in greater patient acceptance, and a placebo-controlled trial is clearly needed to support or refute these preliminary findings.
Fluoxetine in the treatment of premenstrual syndrome.
TLDR
Preliminary results suggest that fluoxetine is an effective and well-tolerated treatment for severe PMS.
Fluoxetine's spectrum of action in premenstrual syndrome
TLDR
Fluoxetine's efficacy extended over a range of affective, physical and behavioural symptoms; its superiority obtained whether it preceded or followed placebo; and the relationship between steady-state drug level and clinical outcome was assessed.
Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
TLDR
The comparison of 2 classes of antidepressants strongly favored the serotonergic drug, which effectively reduced symptoms and improved functioning and was well tolerated by women with severe premenstrual syndrome.
Fluoxetine in the treatment of premenstrual syndrome.
Female Sexual Side Effects Associated with Selective Serotonin Reuptake Inhibitors: A Descriptive Clinical Study of 33 Patients
TLDR
It is suggested that SSRI-associated female sexual dysfunction occurs at a higher rate than previously thought, equal potentials in implicating female sexual side effects among three SSRIs, and the absence or the low incidence of female sexual adverse effects from bupropion.
Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder.
TLDR
Fluoxetine was significantly superior to bupropion and placebo as an effective treatment for PMDD, and patient satisfaction was far greater with fluoxettine.
Open Trial of Fluoxetine Therapy for Premenstrual Syndrome
  • M. Elks
  • Psychology, Medicine
    Southern medical journal
  • 1993
TLDR
It is unclear whether such a strong positive response to fluoxetine, an antidepressant with particularly good effects in “atypical depression,” indicates that the women affected by severe PMS have a cyclic, hormonally induced change in brain chemistry causing a depressive type of condition.
...
...